Friday, July 6, 2018

(Reuters) - Japanese drugmaker Eisai Co and Biogen Inc said that the final analysis of a mid-stage trial of their Alzheimer's drug showed positive results for patients who received the highest dose.


from Reuters: Health News https://ift.tt/2zfkZKb

Related Posts:

  • LATEST HEALTH NEWSJuul Labs Inc confirmed on Tuesday it will stop selling its fruit-flavored vaping pods in Canada, a move that could help the e-cigarette maker stave off mounting scrutiny over the surging popularity of its products with teena… Read More
  • LATEST HEALTH NEWS(Reuters Health) - - The "list price" for healthcare treatments can vary wildly and may not reflect what will appear on a patient's bill, a new study finds. from Reuters: Health News https://ift.tt/3ahsC17 … Read More
  • LATEST HEALTH NEWS(Reuters Health) - People who have weight-loss surgery are more likely to achieve remission of diabetes than those who try to shed excess pounds by dieting and exercising, a recent study suggests. from Reuters: Health Ne… Read More
  • LATEST HEALTH NEWSA third person has died in Brazil of suspected poisoning from a batch of craft beer contaminated with a toxic chemical used in antifreeze and other products, police in the state of Minas Gerais said on Thursday. from Reu… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Common myths about low back pain could lead to more pain, ineffective care and unwarranted anxiety, researchers say. from Reuters: Health News https://ift.tt/35YVBn3 … Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner